SCHEMBL328662

SCHEMBL328662

CN(CCN(CC(N)=O)S(=O)(=O)c1cc(F)c(Oc2ccc(Cl)cc2)c(F)c1)C(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39
DAGLA Q9Y4D2 2/20 0.38
SLC6A7 Q99884 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MCHR1 Q99705 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LPAR1 Q92633 2/20 0.35
LPAR5 Q9H1C0 2/20 0.35
ADAMTS5 Q9UNA0 1/20 0.35
UTS2R Q9UKP6 4/20 0.35
MAPT P10636 1/20 0.35
PGR P06401 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL328646 0.90 MMP13 (0.46) MEN1KMT2AATMDAGLATDP1
SCHEMBL328658 0.88 HSP90AA1 (0.41) DAGLATDP1SMN1; SMN2L3MBTL1MAPT
SCHEMBL328473 0.85 F13A1 (0.41) DAGLAMAPTPGR
SCHEMBL6850664 0.82 DAGLA (0.43) ATMDAGLAL3MBTL1PGR
SCHEMBL328477 0.81 CA1 (0.35) KMT2ADAGLAL3MBTL1UTS2R
SCHEMBL328414 0.81 DAGLA (0.37) KMT2ADAGLASMN1; SMN2L3MBTL1PGR
SCHEMBL328548 0.81 DAGLA (0.37) KMT2ADAGLASMN1; SMN2L3MBTL1MAPT
SCHEMBL328661 0.81 KMT2A (0.38) KMT2ADAGLATDP1L3MBTL1
SCHEMBL328478 0.79 LMNA (0.35) DAGLA
SCHEMBL6850484 0.79 DAGLA (0.36) KMT2ADAGLATDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1511488-B1 HUMAN ADAM-10 INHIBITORS SYMPHONY EVOLUTION INC (US) 2013-05-22 EP disclosed
EP-2428509-A1 Human adam-10 inhibitors Symphony Evolution, Inc. (US) 2012-03-14 EP disclosed
WO-2011011181-A1 PHARMACOLOGICAL CHAPERONES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AMICUS THERAPEUTICS, INC. (US) 2011-01-27 WO disclosed